Clinical Trials Browser

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Locally Advanced Rectal Cancer

Colonic Neoplasms

Pathologic Complete Response, Rectal Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Small Cell Lung Cancer Extensive Stage

Lymphoma, Follicular, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Neoadjuvant Therapies

Colonic Neoplasms

First-line Advanced NSCLC Patients

Biliary Tract Neoplasms

Locally Advanced Colorectal Carcinoma

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NSCLC Stage IV Without EGFR/ALK Mutation

Locally Advanced Rectal Cancer (LARC)

Carcinoma, Non-Small-Cell Lung

Stomach Neoplasms

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

Advanced NSCLC

Advanced NSCLC

Carcinoma, Non-Small-Cell Lung

Adenoviridae Infections, Chondrosarcoma, Neoplasms, Sarcoma

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Neoplasm, Residual

Esophageal Neoplasms

Uterine Cervical Neoplasms

Carcinoma, Non-Small-Cell Lung

Malignant Ascites

Colorectal Neoplasms

Hyperthermia

Locally Advanced Rectal Cancer

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Rectal Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Urinary Bladder Neoplasms

Clinical Trials

INS-ESCC-CT

TORCH-iTNT

TRIUNITE-08

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

JACKPOT38

PRISM-TNBC

SKY

Lalo

Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma

MODIFI-CC

MODIFI-L

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients

An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.

Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases

STELLARIII

PROPHET

A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis

Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI

BETA-PRIME

ATPase

ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer

VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS

Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy

Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer

CONFIRM

The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites

Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer

PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC

SILAR

Whole-target Consolidation Therapy Under Systemic Therapy for Oligometastatic Nasopharyngeal Carcinoma

Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma

Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer